Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

The Allen Institute is employing AWS Cloud and machine learning to decode brain mysteries

By Brian Buntz | June 13, 2023

Allen Institute AWS brain decoding showcases spread of digital brain connections. Artificial intelligence and the idea of neural networks. Concept for mapping the brain's neuronal connections and connectome. Generative AI

[2ragon/Adobe Stock]

High-resolution mapping of the human brain involves managing and interpreting a colossal amount of data. Shoaib Mufti, the head of data and technology at the Allen Institute for Brain Science, described the organization’s approach to these challenges in a recent interview. The project uses artificial intelligence to analyze millions of data points from brain imaging and genetic data, akin to the Human Genome Project.

Allen Institute’s AI-driven brain decoding

Mufti’s team at the Allen Institute is aiming to map the human brain at a cellular level. Their work has led to the creation of a genome-scale Allen Mouse Brain Atlas, a comprehensive, freely accessible online resource for neuroscience research, housing over 20,000 genes and more than 650,000 images.

The Allen Institute uses several AWS Cloud services to manage and analyze the vast amounts of data. They use Amazon’s data lake for analyzing large, diverse datasets, Amazon S3 (Simple Storage Service) for data archiving and backup, DynamoDB for handling large-scale databases and SageMaker for building, training and deploying machine learning models.

The Allen Institute’s strategy for data democratization involves enabling wide accessibility to complex data through natural language processing (NLP) and the use of Amazon Bedrock. Bedrock, an AWS service, supports the development and scaling of applications based on generative AI and foundation models.

Large-scale collaboration for future goals

The Allen Institute’s work is part of a broader collaboration with funding from the National Institutes of Health’s Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative and The BRAIN Initiative Cell Atlas Network, or BICAN. In addition to human brain mapping, the initiative also aims to create detailed atlases of macaque and marmoset brains.

The AWS Cloud platform facilitates collaboration across diverse communities. It serves not only as a repository for data but also as a hub for applications that can interact with this data, acting as an ‘App Store’ for data and applications.

Objectives and future plans

The short-term goal of the initiative revolves around enhancing natural language processing (NLP) capabilities, allowing users to interact with the system using natural language queries. In the medium-term, the focus shifts to machine learning pipelines for data processing, from labeling to segmentation, which can lead to significant time and effort savings for researchers. In the long run, the institute aims to develop a large language model capable of understanding seemingly unrelated data sets, potentially unlocking new discoveries within the extensive data generated by brain mapping studies.

Using both AI and the cloud, the Allen Institute aims to bring together diverse communities and leverage the broader ecosystem. “Services like the Amazon Marketplace are crucial in this regard,” Mufti noted. “We aim to create not just a data repository but also a platform for applications that can interact with this data. We’re building an ‘App Store’ where users can either bring their own apps or data.” This strategy underscores the Allen Institute’s commitment to innovation and community engagement in their AWS-assisted quest to decode the brain’s mysteries.


Filed Under: Brain Breakthroughs, Data science, machine learning and AI, Neurological Disease
Tagged With: AI in Neuroscience, Allen Institute, AWS Cloud, Brain Research, Data Integration, machine learning, Neuroscience
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at [email protected].

Related Articles Read More >

Novo Nordisk in the Drug Discovery & Development Pharma 50
Novo Alzheimer’s trial disappoints as amycretin shines
Shifting mindsets all around: clinical thinking about Alzheimer’s disease moves from symptoms treatment toward earlier intervention and prevention
Quanterix VP: Why biomarkers are no longer supplemental
Texas sues Kenvue claiming it hid link between Tylenol and autism
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE